New and updated preclinical and clinical data presented by biopharma firms at the ENDO 2021, the Endocrine Society's annual meeting, including: 89bio, Amolyt, Biomarin, Bridgebio, Chiasma, Clarus, Crinetics, Lumos, Neurocrine, Strongbridge, Rezolute, Rhythm, Theratechnologies.